Delivery Order SPE2DB20D2014-SPE2DB25FA21G
Award Date
10/28/24
Potential Completion Date
10/29/24
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,620.35, is for the delivery of Novolin 70-30 Flexpen 3mL, a medication used to manage diabetes. The delivery order has a firm fixed price and an ultimate completion date of December 20, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,028.04, is for the delivery of NOVOLIN R 100 UNIT/ML FLEXPEN 3ML, a type of insulin medication. The contract is a firm fixed-price delivery order with a period of performance through January 8, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NovologTM 100 unit/mL FlexPen 3mL insulin products. The contract has a ceiling value of $1,752.15 and is set to expire on June 7, 2023. This contract is a child of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Novolin 70-30 Flexpen 3mL pharmaceutical products. The contract has a firm fixed price of $1,661.48 and a completion date of September 7, 2023. It is a delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of NovologTM 100 unit/mL FlexPen 3mL, a prescription insulin medication. The fixed-price, firm-fixed-price contract has a ceiling value of $1,327.70 and an ultimate completion date of July 19, 2024. AmerisourceBergen, a major pharmaceutical distributor, was awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $3,868.51 Firm Fixed Price Delivery Order covers the supply of Novolin 70-30 Flexpen 3ML, a type of insulin medication used to treat diabetes. The contract has an ultimate completion date of September 13, 2021 and was awarded on September 10, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $3,999.40, is for the delivery of Novolin N 100 Unit/mL Flexpen 3mL, a type of insulin product. The contract has an ultimate completion date of January 31, 2024, and is a Firm Fixed Price Delivery Order. The contract was awarded on January 30, 2024, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
The federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,758.27 firm fixed-price delivery order is for the supply of NOVOLIN N 100 UNIT/ML FLEXPEN 3ML, a type of insulin medication. This award is under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC provides a comprehensive...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of NovLog 100 unit/mL FlexPen 3mL insulin products. The contract has a ceiling value of $1,034.21 and a period of performance through June 28, 2024. It is structured as a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of NovLog 100 unit/mL FlexPen 3mL, a diabetes medication. The fixed-price contract has a ceiling value of $3,523.44 and a period of performance through May 8, 2025. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...